Suzhou Medinoah was awarded "National high-tech enterprise"
Medinoah was awarded as "High-tech enterprise" in 2017 National High-tech Enterprise Awards.
Medinoah has built a comprehensive drug development service platform with strong technical strength, including small molecule drug synthesis research platform，process development and optimization platform, global pharmaceutical analytical R&D service platform to provide objective, professional and efficient laboratory R&D and analytical technical support to global pharmaceutical companies. Medinoah’s analytical platform features a wide range of advanced analytical instrument including nuclear magnetic resonance (NMR), triple quadrupole liquid tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS), gas chromatography (GC), liquid chromatography (HPLC), microplate readers, etc., to provide reliable analytical support for research and development projects.
In recent years, Medinoah has been awarded with "Suzhou Service Industry Innovative Demonstration Enterprises", "Suzhou Anticancer Drug and Pharmaceutical Engineering Research Center ", "2016 China's Growing Service Provider Top 100", etc..